ANVS Q1 2026 Earnings WiderthanExpected Loss as Pipeline Progress Continues MUSA Q1 2026 Earnings Massive EPS Beat Defies Light Revenue Disclosure Stock Slips VHC Q2 2025 Earnings Net Loss of 099 Per Share as Stock Surges on Strategic Developments InMed Pharmaceuticals Q3 2025 Earnings Continued Losses as Stock Declines RAPP Q1 2026 Earnings SmallerthanExpected Loss Boosts Investor Sentiment XRAY Q1 2026 Earnings EPS Misses Expectations Amid Uncertain Revenue Visibility